Loading stock…

Celanese Corporation (CE) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Celanese Corporation

CEMarket cap $4.92BPrice $44.9

Country🇺🇸United States

SectorMaterials

IndustryChemicals

Produces engineered chemicals and materials that show up in car parts, filters, textiles, and medical devices worldwide. It's one of the largest acetyl products makers on Earth, turning basic chemistry into everyday essentials most people never notice.

In Bastion Portfolios?

52W Return+12%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-0%3

Revenue Forecast

Rev CAGR (1y)+5%4

Rev CAGR (3y)+3%2

Rev CAGR (5y)+1%1

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+6%6

EPS Growth Y+3+20%8

Quality

Margins

EBIT Margin10%4

Net Income Margin-12%1

Free Cash Flow Margin7%5

Debt

Net Debt/EBITDA6.11

Efficiency

ROE-25%1

ROA-5%1

Earnings Stability66

GEAR+WEAK16

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)810

P/E Ratio (Forward 3y)610

P/BV1.29

EV Multiples

EV/EBITDA Fwd78

EV/EBIT Fwd118

Yield

Free Cash Flow Yield14.4%10

Dividend Yield0.3%1

Momentum

Short term

1 month return+0%8

3 month return-8%4

YTD return+6%6

Mid term

Price vs 52wHigh63%2

1 year return+6%5

Long term

3 year return-62%1

5 year return-70%1

Risk Shield

Price Risk

Beta0.76

Volatility53%3

Free Cash Flow

Free Cash Flow Margin7%5

Free Cash Flow Yield14.4%10

Quality

ROCE5%3

Earnings Stability66

Net Debt/EBITDA6.11

02Growth

Is it actually growing, and how fast?

CECelanese

Revenue FY25$10.3B

GROWTH RATING↗

VERY WEAK13 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-0%3

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+3%2

Revenue, next 5Y, CAGR+1%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+6%6

EPS growth, FY28E+20%8

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

After shrinking over the last 3 years, revenue is set to grow 3%/yr from here.

WEAKNESSES

Growth is the weak spot here, trailing 87% of companies worldwide.

Revenue held flat over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 1%/yr, behind 90% of companies worldwide.1/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that's turning around. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK18 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+0%8

3-month return-8%4

YTD return+6%6

MID & LONG-TERM▾SCORE

% of 52-week high63%2

1-year return+6%5

3-year return-62%1

5-year return-70%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+0%).

WATCH

Returns sit at the market level over three months (-8%) and so far this year (+6%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-62% over three years and -70% over five), behind 90% of the market.

It's up 6% over the past year, but 37% below its 52-week high. That is a touch behind the market.

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Celanese Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CECelanese

Revenue FY25$10.3B

GROWTH RATING↗

VERY WEAK13 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-0%3

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+3%2

Revenue, next 5Y, CAGR+1%1

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+6%6

EPS growth, FY28E+20%8

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

After shrinking over the last 3 years, revenue is set to grow 3%/yr from here.

WEAKNESSES

Growth is the weak spot here, trailing 87% of companies worldwide.

Revenue held flat over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 1%/yr, behind 90% of companies worldwide.1/10

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Stalled Business

Growth is a weak point here: a business that's turning around. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK18 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+0%8

3-month return-8%4

YTD return+6%6

MID & LONG-TERM▾SCORE

% of 52-week high63%2

1-year return+6%5

3-year return-62%1

5-year return-70%1

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+0%).

WATCH

Returns sit at the market level over three months (-8%) and so far this year (+6%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-62% over three years and -70% over five), behind 90% of the market.

It's up 6% over the past year, but 37% below its 52-week high. That is a touch behind the market.

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Celanese Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community